ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 109–120 of 220 project topics
Real-time Molecular Oncology Data Integration and Reporting Platform
A cloud-based laboratory information system (LIS) that consolidates genomic, proteomic, and clinical data into standardized, interpretable reports for oncologists and tumor boards. Diagnostic labs and hospital systems leverage this to streamline workflows, improve turnaround times, and expand molecular testing revenue streams.
Molecular Oncology Regulatory Strategy Tools Click to view more details →
Prognostic and Predictive Signature Development and Validation Suite
A comprehensive commercial toolkit for developing, validating, and implementing molecular signatures that predict cancer prognosis and therapeutic response across patient cohorts. This enables diagnostics companies and pharma to create premium companion diagnostic products that command premium pricing and expand precision medicine market share.
Molecular Oncology Regulatory Strategy Tools Click to view more details →
AI-Powered Mutation Database Platform for Oncology
SaaS platform that aggregates, annotates, and predicts pathogenic mutations across cancer genomes using machine learning models trained on clinical datasets. Enables pharmaceutical companies and diagnostic labs to rapidly identify druggable targets and reduce time-to-market for precision oncology therapeutics.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Real-Time Tumor Evolution Monitoring Software Suite
Commercial tool that tracks clonal dynamics and resistance mechanisms through longitudinal genomic sequencing data integration and visualization. Delivers actionable insights for oncologists to optimize treatment selection and generate recurring revenue through subscription-based clinical decision support.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Immunotherapy Response Prediction Analytics Engine
Proprietary platform leveraging biomarker signatures and molecular profiling to predict patient response to checkpoint inhibitors and CAR-T therapies. Monetizes through licensing agreements with biopharma companies and clinical validation partnerships that enhance trial enrollment and patient stratification.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Patent Landscape Intelligence System for Oncology Targets
Enterprise software that maps patent filings, drug development pipelines, and IP strategies across actionable cancer mutations and molecular pathways. Provides competitive intelligence and freedom-to-operate analysis that commands premium licensing fees from biotech and pharma R&D departments.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Gene Expression Profiling Data Marketplace Platform
B2B SaaS marketplace connecting researchers, clinicians, and pharmaceutical companies with curated, standardized tumor transcriptomics datasets and signatures. Generates revenue through data licensing, API access fees, and premium analytics tools that unlock insights for biomarker discovery.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Synthetic Lethality Target Discovery and Validation Tool
Computational platform identifying and prioritizing synthetic lethal gene pairs in cancer through integrated genomic and functional screening data analysis. Accelerates drug discovery programs for biotech companies, commanding significant upfront and milestone-based licensing fees from pharma partners.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Precision Oncology Variant Interpretation Standards Engine
Web-based clinical decision support tool that standardizes and automates molecular tumor classification using ASCO, CAP, and AMP guidelines. Captures recurring revenue from hospital systems and commercial labs through certification compliance, reporting, and integration services.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Epigenetic Landscape Mapping for Cancer Drug Development
Advanced analytics platform that decodes chromatin remodeling patterns and methylation signatures to identify novel therapeutic vulnerabilities in solid and hematologic tumors. Delivers product licensing and research collaboration revenue streams from large pharma seeking differentiated epigenetic drug targets.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Tumor Microenvironment Cell Interaction Analysis Platform
Commercial software tool that integrates single-cell sequencing, spatial transcriptomics, and imaging data to map immune-tumor ecosystem dynamics and predict immunotherapy efficacy. Generates service revenue through data analysis contracts and platform licensing to immuno-oncology research institutions.
Molecular Oncology IP & Strategy Analytics Click to view more details →
Liquid Biopsy Biomarker Discovery and Validation Suite
Integrated bioinformatics platform for identifying and validating circulating tumor DNA, RNA, and protein signatures for cancer detection and monitoring. Enables in vitro diagnostics companies to develop companion diagnostic products and capture recurring revenue through royalty agreements and lab partnerships.
Molecular Oncology IP & Strategy Analytics Click to view more details →